KBL Merger (Unit)
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch KBLMU and buy or sell other stocks, ETFs, and their options commission-free!About KBLMU
ETHZilla Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J.
CEOMcAndrew A. Rudisill
CEOMcAndrew A. Rudisill
Employees3
Employees3
HeadquartersPalm Beach, Florida
HeadquartersPalm Beach, Florida
Founded2016
Founded2016
Employees3
Employees3
KBLMU Key Statistics
Market cap5.06M
Market cap5.06M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume348.40
Average volume348.40
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$14.52
52 Week high$14.52
52 Week low$7.62
52 Week low$7.62
Stock Snapshot
As of today, KBL Merger (Unit)(KBLMU) shares are valued at $8.38. The company's market cap stands at 5.06M.
During the trading day, KBL Merger (Unit)(KBLMU) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for KBL Merger (Unit)(KBLMU) stock has reached 0, versus its average volume of 348.4.
The stock's 52-week range extends from a low of $7.62 to a high of $14.52.
The stock's 52-week range extends from a low of $7.62 to a high of $14.52.